author-photo

Rashida Z. Mustafa

National Institutes of Health

7

Papers

368

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Treatment with Ibrutinib Inhibits BTK- and VLA-4–Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (68)
Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study

2014 Leukemia
Show All
- Source
- Cite
- Save
Citations (128)
Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL

2014 Blood
Show All
- Source
- Cite
- Save
Citations (165)
Abstract LB-141: Potent single agent activity of Ibrutinib (PCI-32765) in patients with chronic lymphocytic leukemia (CLL): clinical and translational results from an ongoing phase II study.

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
In Vivo Effects Of Ibrutinib On The Migration Of Chronic Lymphocytic Leukemia Cells Differ Between Patients and Reduce The Ability Of The Bone Marrow Microenvironment To Attract The Tumor Cells

2013 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Effective Inhibition Of Tumor Microenvironment Interactions In CLL Patients Treated With The BTK Inhibitor Ibrutinib Results In Sustained Inhibition Of Tumor Proliferation and Survival Pathways

2013 Blood
Show All
- Source
- Cite
- Save
Citations (0)